NEW YORK, July 21, 2017 -- Greystone, a real estate lending, investment and advisory company, announced it has provided a $78,399,600 HUD-insured permanent loan to refinance Boro Park Center for Nursing & Rehabilitation, a skilled nursing facility in Brooklyn, New York. The transaction was originated by Fred Levine, Managing Director in Greystone’s Monsey, NY office.
The transaction marks one of the largest-ever HUD loans for a skilled nursing facility, and caps over $200 million in total financing provided by Greystone for Centers Health Care. The facility was struggling financially when Centers Health Care purchased it over five years ago, and the principles have invested over $20 million in renovations and remained dedicated to transforming an underperforming facility into one of the finest facilities in the country.
Boro Park Center, which maintains a 5-star Medicaid rating, provides a diverse range of services and amenities for its residents. Its clinical services include Amputee Recovery and Training; Cardiac Therapy; Comfort Care & Palliative Care; Dental Services; Isolation Rooms; Occupational Therapy; Oxygen Management; PICC Management; Physical Therapy; Pleurx Management; Post-Surgical Orthopedic Care; Respiratory Management; Speech Therapy; Stroke Rehabilitation; and Tracheostomy Care.
The Brooklyn facility includes two entire floors dedicated to celebrating Asian cultures, creating a comforting and familiar environment for residents and their interactions with staff fluent in Mandarin, Cantonese and Toishanese. Additionally, the facility offers a separate environment that observes Orthodox Jewish customs, providing Glatt Kosher cuisine as well as access to familiar lifestyle experiences including Shabbat room and Shul with daily Shiurim.
“The Boro Park Center is truly an amazing facility,” said Mr. Levine. “The interior is beautiful, the care is exemplary and the energy in the building is very special. We appreciate the trust Centers Health Care continues to place in us to provide them with financing that enables them to continue to provide world class care to their residents.”
About Greystone
Greystone is a real estate lending, investment and advisory company with an established reputation as a leader in multifamily and healthcare finance, having ranked as a top FHA and Fannie Mae lender in these sectors. Our range of services includes commercial lending across a variety of platforms such as Fannie Mae, Freddie Mac, CMBS, FHA, USDA, bridge and proprietary loan products. Loans are offered through Greystone Servicing Corporation, Inc., Greystone Funding Corporation and/or other Greystone affiliates. For more information, visit www.greyco.com.
PRESS CONTACT: Karen Marotta Greystone 212-896-9149 [email protected]


Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Italy Fines Apple €98.6 Million Over App Store Dominance
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 



